转位蛋白与神经退行性疾病

Abstract
Figure/Table
References
Related Citation (4)

[1]	Braestrup C,Squires R F.Specific benzodiazepine receptors in rat brain characterized by high- affinity (3H) diazepam binding [J]. Proc Natl Acad Sci, 1977,74(9): 3805-3809.
[1]	Braestrup C,Squires R F.Specific benzodiazepine receptors in rat brain characterized by high- affinity (3H) diazepam binding [J]. Proc Natl Acad Sci, 1977,74(9): 3805-3809.
[2]	Braestrup C, Albrechtsen R, Squires R F. High densities of benzodiazepine receptors in human cortical areas[J]. Nature,1977,269(5630): 702-704.
[2]	Braestrup C, Albrechtsen R, Squires R F. High densities of benzodiazepine receptors in human cortical areas[J]. Nature,1977,269(5630): 702-704.
[3]	Zisterer D M, Williams D C. Peripheral-type benzodiazepine receptors [J]. Gen Pharmacol, 1997, 29(3):305-314.
[3]	Zisterer D M, Williams D C. Peripheral-type benzodiazepine receptors [J]. Gen Pharmacol, 1997, 29(3):305-314.
[4]	Papadopoulos V, Baraldi M, Guilarte T R, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function [J]. Trends Pharmacol Sci, 2006, 27(8): 402-409.
[4]	Papadopoulos V, Baraldi M, Guilarte T R, et al. Translocator protein (18kDa): new nomenclature for the peripheral-type benzodiazepine receptor based on its structure and molecular function [J]. Trends Pharmacol Sci, 2006, 27(8): 402-409.
[5]	Rupprecht R, Papadopoulos V, Rammes G, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders [J]. Nat Rev Drug Discov, 2010, 9(12): 971-988.
[5]	Rupprecht R, Papadopoulos V, Rammes G, et al. Translocator protein (18 kDa) (TSPO) as a therapeutic target for neurological and psychiatric disorders [J]. Nat Rev Drug Discov, 2010, 9(12): 971-988.
[6]	Tu L N, Morohaku K, Manna P R, et al. Peripheral benzodiazepine receptor/translocator protein global knockout mice are viable with no effects on steroid hormone biosynthesis [J]. J Biol Chem, 2014, 289(40): 27444-27454.
[6]	Tu L N, Morohaku K, Manna P R, et al. Peripheral benzodiazepine receptor/translocator protein global knockout mice are viable with no effects on steroid hormone biosynthesis [J]. J Biol Chem, 2014, 289(40): 27444-27454.
[7]	Kumar A, Muzik O, Shandal V, et al. Evaluation of age-related changes in translocator protein (TSPO) in human brain using (11)C-[R]-PK11195 PET [J]. J Neuroinflammation, 2012, 9: 232.
[7]	Kumar A, Muzik O, Shandal V, et al. Evaluation of age-related changes in translocator protein (TSPO) in human brain using (11)C-[R]-PK11195 PET [J]. J Neuroinflammation, 2012, 9: 232.
[8]	Lang S. The role of peripheral benzodiazepine receptors (PBRs) in CNS pathophysiology [J]. Curr Med Chem, 2002, 9(15): 1411-1415.
[8]	Lang S. The role of peripheral benzodiazepine receptors (PBRs) in CNS pathophysiology [J]. Curr Med Chem, 2002, 9(15): 1411-1415.
[9]	陈春富,郎森阳,左萍萍, 等. D-半乳糖致衰老大鼠脑海马外周型苯二氮受体改变及其与认知行为的相关研究[J]. 中华医学杂志, 2006,86(21):1470-1473.
[9]	陈春富,郎森阳,左萍萍, 等. D-半乳糖致衰老大鼠脑海马外周型苯二氮受体改变及其与认知行为的相关研究[J]. 中华医学杂志, 2006,86(21):1470-1473.
[10]	Brown R C, Han Z, Cascio C, et al. Oxidative stress-mediated DHEA formation in Alzheimercs disease pathology[J]. Neurobiol Aging, 2003,24(1):567-572.
[10]	Brown R C, Han Z, Cascio C, et al. Oxidative stress-mediated DHEA formation in Alzheimercs disease pathology[J]. Neurobiol Aging, 2003,24(1):567-572.
[11]	Ji B, Maeda J, Sawada M, et al. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer’s and other CNS pathologies [J]. J Neurosci, 2008, 28(47): 12255-12267.
[11]	Ji B, Maeda J, Sawada M, et al. Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer’s and other CNS pathologies [J]. J Neurosci, 2008, 28(47): 12255-12267.
[12]	Chen, M K, Baidoo K, Verina T, et al. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization [J]. Brain, 2004,127(Pt 6):1379-9132.
[12]	Chen, M K, Baidoo K, Verina T, et al. Peripheral benzodiazepine receptor imaging in CNS demyelination: functional implications of anatomical and cellular localization [J]. Brain, 2004,127(Pt 6):1379-9132.
[13]	Boche D, Nicoll JA. Neuroinflammation in ageing and in neurodegenerative disease [J]. Neuropathol Appl Neurobiol,2013, 39(1): 1-2.
[13]	Boche D, Nicoll JA. Neuroinflammation in ageing and in neurodegenerative disease [J]. Neuropathol Appl Neurobiol,2013, 39(1): 1-2.
[14]	Bae K R, Shim H J, Balu D, et al. Translocator Protein 18 kDa Negatively Regulates Inflammation in Microglia [J]. J Neuroimmune Pharmacol, 2014,9(3):424-437.
[14]	Bae K R, Shim H J, Balu D, et al. Translocator Protein 18 kDa Negatively Regulates Inflammation in Microglia [J]. J Neuroimmune Pharmacol, 2014,9(3):424-437.
[15]	Tokay T, Hachem R, Masmoudi-Kouki O, et al. Beta-amyloid peptide stimulates endozepine release in cultured rat astrocytes through activation of N-formyl peptide receptors [J]. Glia, 2008,56(13):1380-1389.
[15]	Tokay T, Hachem R, Masmoudi-Kouki O, et al. Beta-amyloid peptide stimulates endozepine release in cultured rat astrocytes through activation of N-formyl peptide receptors [J]. Glia, 2008,56(13):1380-1389.
[16]	Irwin R W, Brinton R D. Allopregnanolone as regenerative therapeutic for Alzheimer’s disease: translational development and clinical promise [J]. Prog Neurobiol, 2014,113:40-55.
[16]	Irwin R W, Brinton R D. Allopregnanolone as regenerative therapeutic for Alzheimer’s disease: translational development and clinical promise [J]. Prog Neurobiol, 2014,113:40-55.
[17]	Ferrarese C, Appollonio I, Frigo M, et al. Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia [J]. Neurology, 1990,40(4):632-635.
[17]	Ferrarese C, Appollonio I, Frigo M, et al. Cerebrospinal fluid levels of diazepam-binding inhibitor in neurodegenerative disorders with dementia [J]. Neurology, 1990,40(4):632-635.
[18]	Kannan S, Balakrishnan B, Muzik O, et al. Positron emission tomography imaging of neuroinflammation [J]. J Child Neurol, 2009,24(9): 1190-1199.
[18]	Kannan S, Balakrishnan B, Muzik O, et al. Positron emission tomography imaging of neuroinflammation [J]. J Child Neurol, 2009,24(9): 1190-1199.
[19]	Politis M, Su P, Piccini P. Imaging of microglia in patients with neurodegenerative disorders [J]. Front Pharmacol, 2012, 3: 96.
[19]	Politis M, Su P, Piccini P. Imaging of microglia in patients with neurodegenerative disorders [J]. Front Pharmacol, 2012, 3: 96.
[20]	Pavese N, Gerhard A, Tai Y F, et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study [J]. Neurology, 2006, 66(11): 1638-1643.
[20]	Pavese N, Gerhard A, Tai Y F, et al. Microglial activation correlates with severity in Huntington disease: a clinical and PET study [J]. Neurology, 2006, 66(11): 1638-1643.
[21]	Rissanen E, Tuisku J, Rokka J, et al. In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand 11C-PK11195 [J]. J Nucl Med, 2014, 55(6): 939-944.
[21]	Rissanen E, Tuisku J, Rokka J, et al. In vivo detection of diffuse inflammation in secondary progressive multiple sclerosis using PET imaging and the radioligand 11C-PK11195 [J]. J Nucl Med, 2014, 55(6): 939-944.
[22]	Turner M R, Cagnin A, Turkheimer F E, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C] (R)-PK11195 positron emission tomography study [J]. Neurobiol Dis, 2004, 15(3): 601-609.
[22]	Turner M R, Cagnin A, Turkheimer F E, et al. Evidence of widespread cerebral microglial activation in amyotrophic lateral sclerosis: an [11C] (R)-PK11195 positron emission tomography study [J]. Neurobiol Dis, 2004, 15(3): 601-609.
[23]	Venneti S, Lopresti B J, Wang G, et al. PK11195 labels activated microglia in Alzheimer’s disease and in vivo in a mouse model using PET [J]. Neurobiol Aging, 2009, 30(8): 1217-1226.
[23]	Venneti S, Lopresti B J, Wang G, et al. PK11195 labels activated microglia in Alzheimer’s disease and in vivo in a mouse model using PET [J]. Neurobiol Aging, 2009, 30(8): 1217-1226.
[24]	Hommet C, Mondon K, Camus V, et al. Neuroinflammation and β amyloid deposition in Alzheimer’s disease: in vivo quantification with molecular imaging [J]. Dement Geriatr Cogn Disord, 2014, 37(1-2): 1-18.
[24]	Hommet C, Mondon K, Camus V, et al. Neuroinflammation and β amyloid deposition in Alzheimer’s disease: in vivo quantification with molecular imaging [J]. Dement Geriatr Cogn Disord, 2014, 37(1-2): 1-18.
[25]	Veiga S, Carrero P, Pernia O, et al. Translocator protein 18 kDa is involved in the regulation of reactive gliosis [J]. Glia, 2007, 55(14):1426-1436.
[25]	Veiga S, Carrero P, Pernia O, et al. Translocator protein 18 kDa is involved in the regulation of reactive gliosis [J]. Glia, 2007, 55(14):1426-1436.
[26]	Bordet T, Buisson B, Michaud M, et al. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis [J]. J Pharmacol Exp Ther, 2007, 322(2):709-720.
[26]	Bordet T, Buisson B, Michaud M, et al. Identification and characterization of cholest-4-en-3-one, oxime (TRO19622), a novel drug candidate for amyotrophic lateral sclerosis [J]. J Pharmacol Exp Ther, 2007, 322(2):709-720.
[27]	Barron A M, Garcia-Segura L M, Caruso D, et al.Ligand for translocator protein reverses pathology in a mouse model of Alzheimer’s disease [J]. J Neurosci, 2013, 33(20): 8891-8897.
[27]	Barron A M, Garcia-Segura L M, Caruso D, et al.Ligand for translocator protein reverses pathology in a mouse model of Alzheimer’s disease [J]. J Neurosci, 2013, 33(20): 8891-8897.
[28]	Choi J, Ifuku M, Noda M, et al. Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state [J]. Glia, 2011, 59(2): 219-230.
[28]	Choi J, Ifuku M, Noda M, et al. Translocator protein (18 kDa)/peripheral benzodiazepine receptor specific ligands induce microglia functions consistent with an activated state [J]. Glia, 2011, 59(2): 219-230.
[29]	Choi H B, Khoo C, Ryu J K, et al. Inhibition of lipopolysaccharide-induced cyclooxygenase-2, tumor necrosis factor-alpha and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195 [J]. J Neurochem, 2002, 83(3): 546-555.
[29]	Choi H B, Khoo C, Ryu J K, et al. Inhibition of lipopolysaccharide-induced cyclooxygenase-2, tumor necrosis factor-alpha and [Ca2+]i responses in human microglia by the peripheral benzodiazepine receptor ligand PK11195 [J]. J Neurochem, 2002, 83(3): 546-555.